申请人:Vertex Pharmaceuticals Incorporated
公开号:US20160096807A1
公开(公告)日:2016-04-07
The present disclosure relates to co-crystals comprising N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide (Compound 1) and a co-former and methods for their preparation. The present disclosure further relates to pharmaceutical compositions comprising the co-crystal forms, as well as methods of treatment therewith and kits.
本公开涉及包含N-[2,4-双(1,1-二甲基乙基)-5-羟基苯基]-1,4-二氢-4-氧喹啉-3-羧酰胺(化合物1)和共晶形成剂的共晶体以及它们的制备方法。本公开还涉及包含共晶体形式的制药组合物,以及使用它们的治疗方法和工具包。